L'impurità di Amino Acid usata per sintetizza proteina
Dettaglio di Produttu
| NO | Prudutti | Cas stessu | Indicatore di qualità chjave | |||
| PURITUZA | Max. impurità | RESIDU DI SOLVENTI TOTALE | Umidità | |||
| 1 | Fmoc-β-ala-ah-oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 2 | Fmoc-d-ala-d-ala-oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 3 | Fmoc-β-ala-d-ala-oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 4 | Fmoc-arg (PBF) -arg (PBF) -Oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 5 | Fmoc-β-ala-arg (PBF) -Oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 6 | Fmoc-d-arg (PBF) -D-arg (PBF) -Oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 7 | Fmoc-β-ala-d-arg (PBF) -Oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 8 | FMOC-Homoarg (PBF) -Homoarg (PBF) -Oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 9 | Fmoc-β-ala-homoarg (PBF) -Oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 10 | Fmoc-asn (TRT) -asn (TRT) -Oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 11 | Fmoc-β-ala-asn (TRT) -Oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 12 | FMOC-ASP (OTBU) -asp (otbu) -oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 13 | Fmoc-β-ala-asp (otbu) -oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 14 | Fmoc-cys (TRT) -Cys (TRT) -Oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 15 | Fmoc-β-ala-cys (TRT) -Oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 16 | Fmoc-cys (ACM) -cys (ACM) -Oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 17 | Fmoc-β-ala-cys (ACM) -oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 18 | Fmoc-gln (TRT) -gln (TRT) -Oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 19 | Fmoc-β-ala-gln (TRT) -Oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 20 | Fmoc-glu (otbu) -Glu (otbu) -oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 21 | Fmoc-β-ala-glu (otbu) -oh.H2O | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 22 | Fmoc-β-ala-gly-oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 23 | Fmoc-so (TRT) -HIS (TRT) -Oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 24 | Fmoc-β-ala-u so (TRT) -Oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 25 | Fmoc-Ile-éto-oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 26 | Fmoc-β-ala-Ile-oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 27 | Fmoc-leu-leu-oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 28 | Fmoc-β-ala-leu-oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 29 | Fmoc-d-leu-d-leu-oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 30 | Fmoc-β-ala-d-leu-oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 31 | FMOC-Lys (BOC) -ly (BOC) -Oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 32 | Fmoc-β-ala-lys (boc) -o | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 33 | FMOC-Lys (Alloc) -ly (AlloC) -Oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 34 | Fmoc-β-ala-lys (Alloc) -Oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 35 | Fmoc-met-met-met | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 36 | Fmoc-β-ala-met-oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 37 | Fmoc-orn (boc) -orn (boc) -oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 38 | Fmoc-β-ala-orn (BOC) -Oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 39 | Fmoc-phe-phe-oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 40 | Fmoc-β-ala-phe-oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 41 | Fmoc-d-phe-d-phe-oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 42 | Fmoc-β-ala-d-phe-oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 43 | Fmoc-pro-oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 44 | Fmoc-β-ala-pro-oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 45 | Fmoc-ser (tbu) -ser (tbu) -oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 46 | Fmoc-β-ala-ser (TBU) -Oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 47 | Fmoc-ser (TRT) -Ser (TRT) -Oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 48 | Fmoc-β-ala-ser (TRT) -oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 49 | Fmoc-thr (tbu) -thr (tbu) -oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 50 | Fmoc-β-ala-thr (tbu) -oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 51 | Fmoc-trp (boc) -tpr (boc) -o | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 52 | Fmoc-β-ala-trp (BOC) -Oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 53 | Fmoc-d-trp (boc) -d-trp (boc) -oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 54 | Fmoc-β-ala-d-trp (BOC) -Oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 55 | Fmoc-tyr (tbu) -tr (tbu) -oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 56 | Fmoc-β-ala-tira (tbu) -oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 57 | Fmoc-D-Tyr (et) -D-Tyr (et) -oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 58 | Fmoc-β-ala-d-tyr (et) -oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 59 | Fmoc-tyr (me) -tr (me) -oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 60 | Fmoc-β-ala-tyr-tyr (-oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 61 | Fmoc-Val-Val-Oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 62 | Fmoc-β-ala-oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 63 | Fmoc-d-cit-d-cit-oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 64 | Fmoc-β-ala-D-Cit-oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 65 | Fmoc-β-ala-Dab-oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 66 | Fmoc- (3- (2-naaphyl) -d-ala) 2-oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 67 | Fmoc-β-ala-3- (2-naaphil) -d-ala-oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 68 | Fmoc- (3- (3-Priidinil) -d-ala) 2-Oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 69 | Fmoc-β-ala-3- (3-pirididinil) -D-ala-oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 70 | Fmoc- (4-chloro-d-phe) 2-oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 71 | Fmoc-β-ala-4-chloro-d-phe-oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 72 | Fmoc- (D-4AFH (tbucbm)) 2-oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 73 | Fmoc-β-ala-D-4app (tbucbm) -oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 74 | Fmoc-aph (l-hor) -aph (l-hor) -oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 75 | Fmoc-β-ala-aph (l-hor) -oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 76 | Fmoc-lys (ipr, boc) -ly (iPR, BOC) -Oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 77 | Fmoc-β-ala-lys (IPR, BOC) -Oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 78 | Fmoc-β-ala-aeea-oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 79 | Fmoc-aib-aib-oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 80 | Fmoc-β-ala-Aib-oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 81 | Fmoc-arg-oh | 91000-69-0 | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 82 | H-arg (PBF) -o | 200115-86-2 | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 83 | Fmoc-d-arg-oh | 130752-32-8 | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 84 | HD-arg (PBF) -Oh | 200116-81-0 | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 85 | Fmoc-homoarg-oh.hcl | 208174-14-5 | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 86 | H-Homoarg (PBF) -Oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 87 | Fmoc-d-homoarg-oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 88 | HD-Homoarg (PBF) -Oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 89 | Fmoc-asn-oh | 71989-16-7 | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 90 | H-Asn (TRT) -Oh | 132388-58-0 | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 91 | Fmoc-asp-oh | 119062-05-4-4 | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 92 | H-Asp (OTBU) -Oh | 3057-74-7 | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 93 | Fmoc-cys-oh | 135248-89-4 | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 94 | H-Cys (TRT) -Oh | 2790/7/7 | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 95 | H-Cys (ACM) -OH.HCL | 28798-28-9 | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 96 | Fmoc-glen-oh | 71989-20-3 | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 97 | H-Gln (TRT) -Oh | 102747-84-2 | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 98 | Fmoc-glu-oh | 121343-82-6 | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 99 | H-glu (otbu) -oh.h2o | 2419-56-9 | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 100 | Fmoc-so-oh | 116611-64-4-4 | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 101 | H-u so (TRT) -Oh | 35146-32-8 | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 102 | BOC-u so-oh | 17791-52-5 | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 103 | Fmoc-lys-oh | 105044-45-8 | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 104 | H-Lys (BOC) -Oh | 2418-95-3 | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 105 | H-Lys (Alloc) -Oh | 629/1/9 | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 106 | Fmoc-orn-oh.hcl | 201046-57-3 | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 107 | H-orn (boc) -oh | 13650-49-2 | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 108 | Fmoc-ser-oh | 7374-45-5 | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 109 | H-Ser (TBU) -OH | 18822-58-7 | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 110 | H-Ser (TRT) -Oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 111 | Fmoc-thro-oh.h2o | 73731-37-0 | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 112 | H-DR (TBU) -Oh | 4378-13-6 | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 113 | Fmoc-trp-oh | 35737-15-6 | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 114 | H-trp (boc) -oh | 146645-63-8 | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 115 | Fmoc-d-trp-oh | 86123-11-7 | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 116 | HD-trp (BOC) -Oh | 201290-11-1 | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 117 | Fmoc-tyr-oh | 92954-90-0 | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 118 | H-Tyr (TBU) -Oh | 18822-59-8 | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 119 | Fmoc-d-tyr-oh | 112883-29-1 | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 120 | HD-Tyr (et) -oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 121 | H-Tyr (me) -oh.hcl | 67423-44-3 | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 122 | Fmoc-d-4aph (CBM) -oh | 324017-22-3 | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 123 | HD-4aph (tbucbm) -oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 124 | FMOC-Lys (IPR) -Oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
| 125 | H-Lys (IPR, BOC) -Oh | NA | ≥98.0% | ≤,0% | ≤8,0% | ≤2,0% |
Circa à
Compensazione
Gentolex furnisce i prudutti di grande qualità, se alcuna qualità di u produttu hè risuscitatu da l'cliente in u quadru di u tempu necessaria cù evidenze è a valutazione borsa per attivà a prucedure.
Produzzione
I capacità di prodotti farmaceutichi anu cullatu à tunnellità di toni, e capacità di prudutti chimichi Rende 100TONS + nota + graduale di servità, e capacità sò ben efirate à i clienti in u mondu à u mondu.
Ricerca è sviluppu
Ogni annu, ci hè pianu cunghjettatu da a squadra di r & d differendi novi prudutti, quandu si mette in setu, ogni membru Intattara a rispunsabilità kpi.
